rivastigmin stada 1.5 mg kapseli, kova
stada arzneimittel ag - rivastigmine hydrogen tartrate - kapseli, kova - 1.5 mg - rivastigmiini
rivastigmin stada 3 mg kapseli, kova
stada arzneimittel ag - rivastigmine hydrogen tartrate - kapseli, kova - 3 mg - rivastigmiini
rivastigmin stada 4.5 mg kapseli, kova
stada arzneimittel ag - rivastigmine hydrogen tartrate - kapseli, kova - 4.5 mg - rivastigmiini
rivastigmin stada 6 mg kapseli, kova
stada arzneimittel ag - rivastigmine hydrogen tartrate - kapseli, kova - 6 mg - rivastigmiini
omestad 10 mg enterokapseli, kova
stada arzneimittel ag - omeprazole - enterokapseli, kova - 10 mg - omepratsoli
omestad 20 mg enterokapseli, kova
stada arzneimittel ag - omeprazole - enterokapseli, kova - 20 mg - omepratsoli
omestad 40 mg enterokapseli, kova
stada arzneimittel ag - omeprazole - enterokapseli, kova - 40 mg - omepratsoli
ketesse 25 mg oraaliliuos, annospussi
menarini international operations luxembourg s.a. - dexketoprofen trometamol - oraaliliuos, annospussi - 25 mg - deksketoprofeeni
vocabria
viiv healthcare b.v. - cabotegavir sodium, cabotegravir - hiv-infektiot - antiviraalit systeemiseen käyttöön - vocabria tablets are indicated in combination with rilpivirine tablets for the short-term treatment of human immunodeficiency virus type 1 (hiv-1) infection in adults who are virologically suppressed (hiv-1 rna.
sugammadex fresenius kabi
fresenius kabi deutschland gmbh - sugammadex sodium - neuromuskulaarinen estäminen - kaikki muut terapeuttiset tuotteet - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.